NCT03762590 GENetic Education Risk Assessment and TEsting Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT03761160 Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy Status COMPLETED Phase NA
NCT03749421 Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03740334 Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03736746 Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals Status COMPLETED Phase NA
NCT03735446 Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial Status TERMINATED Phase PHASE1
NCT03717480 Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT03716739 Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency Status COMPLETED Phase PHASE2
NCT03716180 DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03709758 Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03709225 Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer Status COMPLETED Phase NA
NCT03692325 Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia Status COMPLETED Phase PHASE2
NCT03689595 Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE) Status ENROLLING_BY_INVITATION Phase N/A
NCT03683680 Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers Status RECRUITING Phase NA
NCT03681483 RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer Status COMPLETED Phase PHASE1
NCT03679650 Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03675893 RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer Status RECRUITING Phase PHASE2